Literature DB >> 7797087

Oxygen-induced retinopathy in the newborn rat: effects of hyperbarism and topical administration of timolol maleate.

B Ricci1, G Minicucci, A Manfredi, A Santo.   

Abstract

BACKGROUND: Lesions resembling those of human retinopathy of prematurity can be provoked in newborn Wistar rats by exposure to an FiO2 of 80% for the first 5 days of life followed by 5 days recovery under room-air conditions.
METHODS: We evaluated the effects of moderate hyperbarism (+60.75 kPa, i.e. 455 mmHg or 0.6 atm) and topical administration of 0.25% timolol maleate on oxygen-induced retinopathy (OIR) in this experimental model.
RESULTS: OIR (including neovascularization in most cases) was observed in 100% of the retinas of normobaric oxygen-reared ratlings that did not receive timolol. OIR was less frequent in oxygen-reared ratlings treated with hyperbarism (60%) or timolol (65%). Hyperbaric oxygen supplementation combined with timolol treatment during both the hyperoxic and room-air phases reduced the incidence of OIR to 30%. There was no sign of vasoproliferation in any of the retinas from the latter three groups.
CONCLUSIONS: The highly significant protective effects of hyperbarism and timolol observed in this study are not fully understood. We speculate that vasoconstriction induced by the hyperbarism reduces the amount of oxygen that reaches the retina from the choroid during O2 supplementation, while an increased ocular perfusion pressure caused by timolol-induced reduction of the intraocular pressure might decrease the stimulus to vasoproliferation that normally occurs with room-air recovery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797087     DOI: 10.1007/bf00183596

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Effects of hyperbaric, normobaric and hypobaric oxygen supplementation on retinal vessels in newborn rats: a preliminary study.

Authors:  B Ricci
Journal:  Exp Eye Res       Date:  1987-03       Impact factor: 3.467

2.  Intraocular pressure and systemic blood pressure after administration of vasoactive substances in hypertensive and normal rats.

Authors:  R Funk; J W Rohen; K Skolasinska
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

3.  Variations in the severity of retinopathy seen in newborn rats supplemented with oxygen under different conditions of hyperbarism.

Authors:  B Ricci; G Calogero; D Lepore
Journal:  Exp Eye Res       Date:  1989-11       Impact factor: 3.467

4.  Retinal vascular changes after treatment with hyperbaric oxygen.

Authors:  K Herbstein; J B Murchland
Journal:  Med J Aust       Date:  1984-06-09       Impact factor: 7.738

Review 5.  A reexamination of the role of oxygen in retrolental fibroplasia.

Authors:  J F Lucey; B Dangman
Journal:  Pediatrics       Date:  1984-01       Impact factor: 7.124

6.  Reduced severity of oxygen-induced retinopathy in the newborn rat after topical administration of timolol maleate. A preliminary study.

Authors:  B Ricci; G Calogero; A Caprilli; F M Quaranta-Leoni
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

7.  Variable oxygen exposure causes preretinal neovascularization in the newborn rat.

Authors:  J S Penn; B L Tolman; L A Lowery
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-03       Impact factor: 4.799

8.  Vasoconstrictive effect of topical timolol on human retinal arteries.

Authors:  X D Martin; P A Rabineau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

9.  Oxygen-induced retinopathy in newborn rats: effects of prolonged normobaric and hyperbaric oxygen supplementation.

Authors:  B Ricci; G Calogero
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

10.  Effect of topical timolol on the human retinal circulation.

Authors:  J E Grunwald
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-12       Impact factor: 4.799

View more
  4 in total

Review 1.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

Review 2.  Application of a nitric oxide sensor in biomedicine.

Authors:  Carlota Saldanha; José Pedro Lopes de Almeida; Ana Santos Silva-Herdade
Journal:  Biosensors (Basel)       Date:  2014-02-04

3.  Involvement of Renin-Angiotensin System in Retinopathy of Prematurity - A Possible Target for Therapeutic Intervention.

Authors:  Madhu Nath; Parijat Chandra; Nabanita Halder; Baskar Singh; Ashok Kumar Deorari; Atul Kumar; Rajvardhan Azad; Thirumurthy Velpandian
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

Review 4.  Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again.

Authors:  Mitsuru Arima; Yuya Fujii; Koh-Hei Sonoda
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.